Amniotic and placental tissue allografts continue to draw attention across surgical specialties, and one of the best-known products in this category is AMNIOFIX®.
If you are researching AMNIOFIX, it helps to start with a simple question: what is it, and where does it fit within the broader world of surgical biologics?
AMNIOFIX is a placental allograft from MiMedx made from dehydrated human amnion/chorion membrane, often abbreviated DHACM. It is used in surgical settings as a protective barrier on surgical wounds and is part of the broader category of placental tissue allografts used by surgeons across multiple specialties.
This article is intended as an educational overview of the product category and the role AMNIOFIX plays within it.
What Is AMNIOFIX?
AMNIOFIX is a human placental tissue allograft manufactured from donated placental membrane tissue. More specifically, it is composed of dehydrated human amnion/chorion membrane (DHACM).
That means AMNIOFIX is not a synthetic material and not a generic wound dressing. It is a biologic allograft derived from the amnion and chorion, which are two distinct placental membrane layers.
MiMedx describes AMNIOFIX as a product used to provide a protective barrier on surgical wounds. It is offered in sheet and fenestrated configurations and in a variety of sizes, giving surgeons options based on the surgical application and amount of coverage needed.
What Does DHACM Mean?
The abbreviation DHACM stands for:
Dehydrated Human Amnion/Chorion Membrane
That terminology tells you quite a bit about the product:
- Dehydrated means the tissue has been processed and preserved in a dehydrated form.
- Human means the graft is human tissue-derived.
- Amnion/Chorion refers to the placental membrane layers used in the allograft.
- Membrane refers to the thin sheet-like tissue configuration.
This matters because not all placental tissue products are the same. Some products may contain amnion only. Others may contain different placental tissues or use different preservation methods. AMNIOFIX falls into the category of dehydrated placental membrane allografts that incorporate both amnion and chorion.
What Are the Amnion and Chorion?
The amnion and chorion are two distinct placental membrane layers associated with pregnancy and fetal development.
- The amnion is the inner membrane.
- The chorion is the outer membrane.
These tissues have different structures and compositions, and together they form part of the placental membrane system. In the context of surgical biologics, they are important because they can be recovered, processed, and preserved for clinical use as placental tissue allografts.
How AMNIOFIX fits into placental tissue allografts: placenta → amnion and chorion → DHACM → AMNIOFIX.
How Is AMNIOFIX Processed?
According to MiMedx, AMNIOFIX is processed using the company’s PURION® process.
MiMedx describes this process as involving:
- proper handling and cleansing of placental tissue
- preservation of extracellular matrix components
- preservation of key tissue characteristics during processing
- terminal sterilization for an additional level of safety
The product is derived from placental tissue donated by healthy, consenting mothers following live Caesarean section birth in the United States, according to the manufacturer’s published product and processing information.
From an educational standpoint, this is an important concept: processing matters. In placental tissue allografts, the tissue source is only part of the story. The way tissue is recovered, handled, processed, preserved, and sterilized can affect storage, handling characteristics, and product differentiation.
Key Product Characteristics of AMNIOFIX
When someone searches for AMNIOFIX, they are usually trying to understand how it is positioned within the placental allograft space.
At a high level, AMNIOFIX is characterized by several core features:
1. Human placental tissue-derived
AMNIOFIX is derived from donated placental membrane tissue rather than synthetic material.
2. DHACM composition
The allograft is composed of dehydrated human amnion/chorion membrane, placing it within the placental sheet allograft category.
3. Sheet-based configuration
AMNIOFIX is available in thin sheet configurations that can be selected based on the surgical setting and the amount of tissue coverage required.
4. Protective barrier role
MiMedx describes the product as providing a protective barrier on surgical wounds, which is a useful way to understand its basic clinical role.
5. Shelf-stable format
The dehydrated format supports practical storage and handling within clinical environments, subject to the current Instructions for Use.
How Is AMNIOFIX Used in Surgery?
AMNIOFIX is part of MiMedx’s advanced surgical solutions portfolio and is presented by the manufacturer as being used in a variety of surgical settings.
MiMedx’s educational materials list examples such as:
- tendon and ligament repair
- myomectomies
- bunionectomies
- rotator cuff repair
- posterior lumbar interbody fusion (PLIF)
- total knee arthroplasty
- total shoulder arthroplasty
- dehiscence repair
- thyroidectomies
- other surgical wound applications
That does not mean every use example should be interpreted the same way or that all products in the category are interchangeable. It simply means AMNIOFIX is positioned as a surgical placental allograft used across a broad set of procedures and specialties.
For surgeons, the better question is not just “Where has it been used?” but also:
- what tissue does the graft contain?
- how is it processed?
- how does it handle in the OR?
- what sizes and configurations are available?
- what clinical evidence is available for the product?
- what do the current labeling and Instructions for Use say?
Why Surgeons Research AMNIOFIX
From an SEO standpoint, a lot of AMNIOFIX-related searches are really educational intent searches.
People are trying to answer questions such as:
- What is AMNIOFIX?
- Is AMNIOFIX an amniotic graft?
- What does DHACM mean?
- How is AMNIOFIX different from other placental tissue allografts?
- What surgical specialties use AMNIOFIX?
- What should I know before evaluating the product?
That is why it is useful to think of AMNIOFIX within the broader category of surgical biologics rather than as a stand-alone product name.
AMNIOFIX sits at the intersection of:
- placental tissue allografts
- amniotic grafts
- surgical biologics
- sheet allograft technologies
- specialty-specific surgical applications
AMNIOFIX and the Broader Surgical Biologics Category
One of the reasons AMNIOFIX is an important search term is that it serves as an entry point into the much larger conversation around surgical biologics.
Surgical biologics include biologically derived materials used in surgical and wound-related settings. Depending on the category, these may include placental tissue allografts, extracellular-matrix technologies, collagen-based products, tissue-derived barriers, and other biologic platforms.
AMNIOFIX is one example of how placental tissue has been developed into a commercially available surgical allograft format.
For clinicians evaluating products in this space, product identity matters — but so do the broader questions of tissue composition, processing, preservation, sterility, storage, clinical evidence, and intended surgical use.
What Should Surgeons Consider When Evaluating AMNIOFIX?
If a surgeon or facility is evaluating AMNIOFIX, a practical checklist might include:
- Tissue composition
Is the product amnion only, chorion only, or amnion/chorion? - Processing method
How is the tissue cleansed, processed, and preserved? - Sterility and safety
What sterilization method is used, and what do the current product materials say? - Configurations and sizes
What options are available for the intended surgical setting? - Storage and handling
How is the product stored, and how does it behave in the OR? - Clinical evidence
What published data, product information, and medical education materials are available? - Instructions for Use
What does the current manufacturer labeling say about proper use?
These are the kinds of questions that matter far more than simply recognizing the product name.
About 6|Sixty Biologics
6|Sixty Biologics is an independent surgical biologics distributor focused on connecting surgeons and healthcare organizations with advanced biologic technologies across multiple surgical specialties.
Our goal is to provide practical education around the growing field of surgical biologics, including placental tissue allografts, amniotic grafts, and surgeon-focused product categories used in the surgical environment.
To learn more, visit 6sixty.com.
References / Helpful Links
- MiMedx AMNIOFIX Product Overview
https://www.mimedx.com/amniofix/ - MiMedx Processing Overview
https://www.mimedx.com/processing/
Disclosure
6|Sixty Biologics is an independent surgical biologics distributor and is not MiMedx. AMNIOFIX® and PURION® are trademarks of MiMedx Group, Inc. Product information should always be reviewed against current manufacturer materials, labeling, and Instructions for Use.
